This protocol covers vasomotor rhinitis in the specific clinical picture of dominant nasal congestion and nasal obstruction, where rhinorrhea is absent. The absence of rhinorrhea distinguishes this presentation and informs the management approach.
The patient presents with vasomotor rhinitis characterised by nasal congestion and obstruction as the primary complaints, with no rhinorrhea. This obstruction-dominant, rhinorrhea-free pattern is the defining feature of this protocol's scope.
Empiric pharmacological therapy targeting nasal decongestion is a central consideration in this scenario — the specific agents, their selection criteria, and the full management sequence are detailed in the complete protocol.
Goal: improvement in congestionWith nasal congestion and obstruction only, topical corticosteroids would be a wise starting point for therapy.
Consider empiric use of topical decongestants, oral decongestants, or oral antihistamines.
View source ↗